In the 2015 Global CAMEO Enrollment challenge, the dedicated Department of Emergency Medicine research team, led by Principal Investigator Dr. Marie-Carmelle Elie, has risen to the top out of 55 sites in four countries over the last quarter. The CAMEO study aims to recruit patients presenting with symptoms of angioedema, a rapid skin swelling reaction similar to hives. Despite the highly complex enrollment process, the ED research team was quick to mobilize, implement a series of study-related activities, and successfully identify patients that met the criteria. Congratulations to Dr. Elie and the research team for their first place performance on a worldwide level!
According to ClinicalTrials.gov, the CAMEO study is being conducted to compare the safety and efficacy of icatibant with placebo in the treatment of ACE Angiotensin-Converting Enzyme Inhibitor (ACE-I)-Induced Angioedema in Adults.